1) To improve our understanding of COVID-19 transmission in a training environment, including source of the virus, how the virus may have spread so rapidly, and the role of symptomatic/asymptomatic transmission. 2) To improve our understanding of the development of immunity to SARS-CoV-2.
No treatment. SARS-CoV-2 antibody and neutralizing antibody testing.
Roche Elecsys Anti-SARS-CoV-2 assay on the Roche Cobas e System of IgG and IgM; neutralizing antibodies to be conducted via standard Virus Neutralization Test or high sensitivity and specificity commercial Surrogate Virus Neutralization Test